Novozymes announced the inauguration of its Suzhou Hongda Enzymes Company production facility in Taicang, China, about 30 miles north of Shanghai. The company said the new plant , the largest enzyme fermentation facility in the world, would focus on products for the bioethanol industry. Novozymes executive vice president Peder Holk Nielsen said, "We believe bioethanol is a good example how biotechnology can make more from less, decoupling economic growth from the use of natural resources. As the world leader in bioinnovation, Novozymes is optimistic about the future of bioethanol and is dedicated to increasing our capabilities continuously in this field. The Suzhou facility is one of Novozymes' strategic manufacturing locations, and this new expansion will enable us to accomplish more."According to the press release, "Novozymes offers a highly efficient technology platform for sustainable production for bioethanol - getting more out of fewer resources. In 2010 Novozymes will have enzymes available on a large scale for production of second-generation bioethanol based on agricultural byproducts."
Despite the recent downturn in the global economy, Novozymes has increased its investment in Taicang, China, generating more revenue and jobs there. What attracts Novozyme invest more in China?
Why not in the USA?
No comments:
Post a Comment